-
Accounting For Preference Heterogeneity In Discrete-Choice Experiments
-
Are We Ready For A New Approach To Comparing Coverage And Reimbursement Policies For Medical Nutrition In Key Markets
-
Opportunities and Barriers to the Development and Use of Open Source Health Economic Models: A Survey
-
The History and Future of the “ISPOR Value Flower”: Addressing Limitations of Conventional Cost-Effectiveness Analysis
-
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022)
-
Comparisons of Food and Drug Administration and European Medicines Agency Risk Management Implementation for Recent Pharmaceutical Approvals
-
Being Precise About Precision Medicine: Report of the ISPOR Personalized Precision Medicine Special Interest Group
-
Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report
-
ISPOR Science Strategy
-
The Future of HE+OR
-
Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing
-
Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions - Report of the ISPOR Stated Preference Research Special Interest Group
-
Defining Patient Engagement in Research: Results of a Systematic Review and Analysis
-
Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report
-
Value of Information Analytical Methods - Report 2
-
Value of Information Analysis for Research Decisions - An Introduction Report 1
-
Rare Disease Terminology and Definitions - A Systematic Global Review
-
Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group
-
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models
-
Methods for Measuring Multiple Medication Adherence: A Systematic Review
Questions?
For any questions about this report please contact us.